EORTC
@EORTC
European Organisation for #Research and #Treatment of #Cancer defines better treatments for all cancer #patients to prolong survival and improve quality of life
📅 Get ready to make the most of EORTC’s upcoming events! Mark your calendars 👇 #CancerResearch #ClinicalTrials #Oncology #EORTCevents #PatientDays #EBCC15 #Stats2026 #MCCRworkshop #ENASymp26
#ProstateCancer #PragmaticTrial #MetastaticProstateCancer #MensHealthAwareness @cancertrials_ie @sogug1 - Grupo Español de Oncologia Genitourinaria @europa_uomo - The European Prostate Cancer Coalition @GETUG_Unicancer @EU_Commission @EORTC
Had the pleasure of presenting a poster of EORTC 2418 STARBURST-1 at #anzup25. It’s time to validate a clinical multimodal signature of response to neoadjuvant treatment in MIBC! @amassonlecomte @Achard_Verane @GGrisay @y_loriot @BertrandTOMBAL @EORTC @ANZUPtrials
📢 Don’t miss next week’s webinar! Join the EORTC Lung Cancer & PAMM Groups on 22 July to explore how pharmacological interactions impact thoracic oncology treatment. 🔗 Register now: eortc.wufoo.com/forms/z1ov02va… #EORTClung #EORTCpamm #OncologyWebinar #Pharmacology #LungCancer
#LEGATO_Horizon #HorizonEurope #EUCancerMission #CancerResearch #ClinicalTrials #Cancer #BrainTumor #TreatingCancer #glioblastoma #braincancer #glioblastomaawareness #GBMDay @EU_Commission
🧠New publication from the EORTC-BTG-1320 trial: Discover how advanced imaging metrics could improve prognostic accuracy in neuro-oncology. 👇 🔗 Read more: eortc.org/bibliography/ #NeuroOncology #Meningioma #EORTCbrain #CancerResearch
🚨 Fellowship opportunity at EORTC! Passionate about patient-centred research in oncology? Join EORTC’s #QualityofLife team in Brussels for hands-on experience in designing, managing & analysing QoL studies in cancer trials. Apply now 👉 eortc.org/job/fellowship… @EORTC_QLG
🫁 Why do some treatments fail to produce a response in patients, while others cause severe toxicity? Join the EORTC LCG webinar to explore how pharmacological interactions shape outcomes in thoracic oncology 🎙️Speaker: Dr. Veerman 🔗 eortc.wufoo.com/forms/z1ov02va… #EORTCLungCancer
📢Don't miss it! EORTC CEO Denis Lacombe will be speaking at this important event to discuss Treatment Optimisation for Access.
The European Parliament Intergroup on Cancer and Rare Diseases, of which we are a member of the Secretariat, are hosting a public hearing to help shape the path forward for the trilogue negotiations on the General Pharmaceutical Legislation. 📺 Watch: go.eurordis.org/LSvEPV
At EORTC we celebrate this year's Sarcoma Awareness Month by highlighting the @EU_Commission-funded STREXIT 2 project, an observational arm of the EORTC 1809 STRASS 2 phase III international clinical trial on high-risk retroperitoneal sarcoma 👉eortcresearchfund.org/soft-tissue-bo…
@EU_Commission @EORTC
🎉 We’re excited to announce that the first patient has been randomised in the PROLoNG study! 👉eortc.org/research_field… #CancerResearch #ClinicalTrials #Oncology #HeadandNeckCancer #EORTCheadandneck
Submit an abstract by July 21 for the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (October 22-26; Boston), chaired by Ryan B. Corcoran, Tim F. Greten, and Elena Garralda. Learn more: brnw.ch/21wTXMw #Targets25 @EORTC @theNCI
Results from @EORTC EORTC-1607 / ABC-09 presented at @myESMO #ESMOGI25 Advanced BTC First-line CisGem+Pembro Phase II - Biomarker discovery 📸 Full details ⬆️CPS - longer PFS ⬆️CD8/Treg - responders ⬇️PD-L1+CD4, PD-L1+CD8 on treatment (regardless of response) #ESMOAmbassadors
Grateful to @myESMO for the chance to share my perspective on agnostic cancer therapies and their role in advancing precision medicine in GI tumours. Huge thanks to the incredible chairs and speakers of this session - I feel very privileged to have been a part of it. #ESMOGI25
@myesmo #ESMOGI25 @ Francesco Scalafoni is demonstrating how #RealWorldData on TNT in LARC helps resolve uncertainties surrounding this approach—a remarkable global collaborative effort N=1586 elegible pts- @EORTC @incanMX @Juanmaoconnor
📢 At #ESMOGI25 today: EORTC hosts a special session with 5 expert lectures + Q&A on neoadjuvant advances, organ preservation & novel targets in GI oncology (16:30–18:00, Room Valencia). Also: 2 poster displays from 15:30–16:30 (Foyer). @myESMO #EORTCgastrointestinal #GIOncology
🎤“#EUHTA's regulation offers a framework for collaborative assessment, potentially speeding up patient access to new treatments. But it overlooks treatment optimisation & post-licensing studies. Balanced systems are key to patient-centricity,” Denis Lacombe at EU HTA conference.
📍We are in Barcelona for #ESMOGI25. Come and visit us at our booth #25. Don't miss EORTC's special session and poster displays tomorrow. Stay tuned! 👉More info: eortc.org/app/uploads/20… @myESMO #EORTCgastrointestinal #ClinicalTrials #CancerResearch #GastroIntestinalCancer
🧠 New EORTC survey shows PET imaging is widely available and used across European brain tumour centres. With data from 103 centres in 20 countries, the findings support PET-based endpoints in future trials. 🔗 Find out more: eortc.org/blog/2025/07/0… #EORTCbrain
Submit an abstract by July 21 for the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (October 22-26; Boston), chaired by Ryan B. Corcoran, Tim F. Greten, and Elena Garralda. Learn more: brnw.ch/21wTMZT #Targets25 @EORTC @theNCI
🎯 Join us for an EORTC event at the European Parliament hosted by Mrs R. Jerkovic about treatment optimisation: Making Cancer Treatment Accessible & Sustainable in Europe. 📅 25 September 2025 📍 Brussels & Online 👉 eortc.org/event/eortc-ca… #CancerResearch #ClinicalTrials
